Hypertension, Vol 7, 27-31, Copyright © 1985 by American Heart Association
WH Beierwaltes, J Prada and OA Carretero
Numerous studies have suggested that a functional relationship may exist
between the kallikrein-kinin and the renin-angiotensin systems within the
kidney. We investigated the effects of glandular kallikrein on renin
release by using an in vitro preparation of isolated rat glomeruli with
their attendant arterioles. The effect of kallikrein was studied in the
presence or absence of 0.1% bovine serum albumin (BSA) in Krebs superfusion
fluid. We also studied the effect of inactivating kallikrein by treatment
with phenylmethylsulfonyl fluoride or by inhibiting it with aprotinin. In
the absence of BSA, kallikrein caused a 12-fold increase in renin release,
from 5.1 +/- 1.2 ng angiotensin I (ANG I)/min to 66.0 +/- 2.27 ng ANG I/min
(p less than 0.025). In the presence of BSA, renin release increased
twofold, from 13.0 +/- 1.8 ng ANG I/min to 24.3 +/- 4.8 ng ANG I/min (p
less than 0.025). The basal level of renin measured when the glomeruli were
superfused with BSA- Krebs was two to three times greater than when they
were superfused with Krebs alone (p less than 0.001). This finding suggests
that media protein inhibited renin loss during either the superfusion or
storage of renin samples. Neither phenylmethylsulfonyl fluoride-inactivated
nor aprotinin-inhibited kallikrein stimulated renin release. We propose
that kallikrein can stimulate renin release in isolated glomeruli.(ABSTRACT
TRUNCATED AT 250 WORDS)
ARTICLES
Effect of glandular kallikrein on renin release in isolated rat glomeruli
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |